Optimi Health completes development of mushroom facility in B.C.

The Vancouver functional and psychedelic fungi company has applied for a Health Canada dealer’s licence.

Optimi Health Corp. seeks to ride the boom in the market for functional mushrooms and has put a stake in the future of psychedelics.

0

Optimi Health Corp. has announced the substantial completion of its 20,000-square-foot mushroom facility in Princeton, B.C.

The Vancouver-based health and wellness company seeks to grow and process functional or medicinal mushrooms at the location.

These are non-psychedelic fungi that have been traditionally used for herbal remedies and tonics.

Functional mushroom varieties include Reishi, Lions Mane, Chaga, Turkey Tail, and Cordyceps.

In addition, Optimi has set a stake for itself in the future of psychedelic mushrooms.

The company wants to position itself as a producer of psilocybin and psilocin, which are the psychoactive substances found in so-called magic mushrooms.

Through its B.C. facility, the company hopes to later advance into research regarding and sale of these mind-altering elements.

In January 2021, Optimi received a research exemption from Health Canada for psychoactive mushrooms.

Earlier in November 2020, the company applied for a dealer’s licence with the federal agency for the distribution of psilocybin.

There is renewed interest in the potential of psychedelic substances to help treat a range of mental as well as physical health issues, including depression and addictions.

In a September 14, 2021 media release, Optimi announced that it was proceeding with the construction of a portion of the facility that will include a high-security vault that can handle 50 kilograms of psilocybin.

Moreover, the storage capacity can be upgraded in the future to increase capacity to 1,250 kilograms.

In a new release Tuesday (December 7), Optimi indicated that it is ready for a “final site inspection” of its Princeton facility as part of its licence application with Health Canada.

“With the tools we now have available, we are highly confident in our ability to isolate high purity natural psilocybin from our own mushroom harvest,” chief science officer Justin Kirkland said in the release.

Optimi trades in the Canadian Securities Exchange under the ticker symbol OPTI.

Leave your opinion for the editor...We read everything!

Your email address will not be published. Required fields are marked *